MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH
申请人:Tachdjian Catherine
公开号:US20080306053A1
公开(公告)日:2008-12-11
The present invention provides screening methods for identifying modifiers of chemosensory receptors and their ligands, e.g., by determining whether a test entity is suitable to interact with one or more interacting sites within the Venus flytrap domains of the chemosensory receptors as well as modifiers capable of modulating chemosensory receptors and their ligands.
SULPHOXIMINE-SUBSTITUTED QUINAZOLINE DERIVATIVES AS IMMUNO-MODULATORS, THEIR PREPARATION AND USE AS MEDICAMENTS
申请人:NGUYEN Duy
公开号:US20090186911A1
公开(公告)日:2009-07-23
The present invention relates to sulphoximine-substituted quinazoline derivatives of the formula (I), processes for their preparation and their use as a medicament for the treatment of various diseases.
本发明涉及公式(I)的磺氧胺取代的喹唑啉衍生物,其制备方法以及作为治疗各种疾病的药物的用途。
Proline derivatives and use thereof as drugs
申请人:Kitajima Hiroshi
公开号:US20050245538A1
公开(公告)日:2005-11-03
The present invention aims at providing compounds having therapeutic effects due to a DPP-IV inhibitory action, and satisfactory as pharmaceutical products.
The present inventors have found that derivatives having a substituent introduced into the γ-position of proline represented by the formula (I)
wherein each symbol is as defined in the specification, have a potent DPP-IV inhibitory activity, and completed the present invention by increasing the stability.
The present invention aims at providing compounds having therapeutic effects due to a DPP-IV inhibitory action, and satisfactory as pharmaceutical products.
The present inventors have found that derivatives having a substituent introduced into the &ggr;-position of proline represented by the formula (I)
1
wherein each symbol is as defined in the specification, have a potent DPP-IV inhibitory activity, and completed the present invention by increasing the stability.
Sulphoximine-substituted quinazoline derivatives as immuno-modulators, their preparation and use as medicaments
申请人:Bayer Schering Pharma AG
公开号:US07863283B2
公开(公告)日:2011-01-04
The present invention relates to sulphoximine-substituted quinazoline derivatives of the formula (I), processes for their preparation and their use as a medicament for the treatment of various diseases.